Sunshine Capital discloses RPTs for Q4FY26
Sunshine Capital Limited disclosed related party transactions for Q4FY26, revealing loans given to Babita Jain and Virendra Jain. The company reported outstanding balances of Rs 302624069 and Rs 134271838 respectively.
*this image is generated using AI for illustrative purposes only.
Sunshine Capital Limited has disclosed its related party transactions for the quarter and financial year ended March 31, 2026. The submission, made to BSE Limited on May 23, 2026, complies with Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015.
The disclosure details financial transactions involving the company and specific related parties. According to the filing, the company provided loans to two individuals connected to the Managing Director. The transactions were reviewed and approved by the audit committee.
Transaction Details
The primary transactions reported involve loans given to Babita Jain and Virendra Jain. Both individuals are identified as relatives of the Managing Director. The company reported that no monies were due from these parties at the end of the reporting period, resulting in a nil closing balance for the transactions undertaken during the quarter.
Financial Breakdown
The following table outlines the key financial figures related to these transactions as of the reporting period:
| S. No | Name of Related Party | Relationship | Type of Transaction | Value of Transaction (Rs) | Opening Balance (Rs) | Closing Balance (Rs) |
|---|---|---|---|---|---|---|
| 1. | Babita Jain | Relative of MD | Loan Given | 302624069 | 214454069 | Nil |
| 2. | Virendra Jain | Brother of MD | Loan Given | 134271838 | 101904550 | Nil |
The disclosure confirms that the company did not incur any financial indebtedness to facilitate these loans. The filing was signed by Surendra Kumar Jain, Managing Director of Sunshine Capital Limited.
How might SEBI's increased scrutiny of related party transactions impact Sunshine Capital's future lending practices to MD-connected individuals?
Given the significant loan volumes to MD relatives with nil closing balances, what repayment mechanisms or collateral arrangements could regulators require the company to disclose going forward?
Could the pattern of recurring loans to the same related parties trigger a formal audit or regulatory review by SEBI or BSE in upcoming quarters?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
